BioCentury | Jun 9, 2020
Finance

June 8 Financial Quick Takes: Novo’s REPAIR fund issues call for AMR proposals; B rounds for MabPlex, Clover; A rounds for Shorla, Curesponse

...Group, OrbiMed, China Merchants Securities, Xinzhen Tianying Fund, GF Venture Capital, Huachen Finance, Finnova Capital, Horus...
BioCentury | Mar 30, 2017
Financial News

Vect-Horus completes venture financing

...Drug delivery company Vect-Horus (Marseille, France) raised €2.5 million ($2.7 million) in a venture round from...
...round from private shareholders, including Banque Populaire Méditerranée on March 22. Vect-Horus , Marseille, France Alex Himes Vect-Horus...
BioCentury | Jul 27, 2015
Company News

Vect-Horus, Servier deal

...The companies partnered to generate new chemical entities by applying Vect-Horus’ vector technology to CNS drug...
...imaging agents using endogenous transport mechanisms across the blood-brain barrier to treat undisclosed CNS diseases. Vect-Horus...
...depending on the success of the collaboration, the companies will discuss a license under which Vect-Horus...
BioCentury | Dec 22, 2014
Financial News

Vect-Horus completes venture financing

...Vect-Horus , Marseille, France Business: Drug delivery, Neurology Date completed: 2014-12-15 Type: Venture financing Raised: €1.5...
BioCentury | Dec 9, 2013
Company News

Advanced Accelerator Applications, Vect-Horus deal

...The companies partnered to develop molecules to treat neurological diseases. Vect-Horus will use its vector technology...
...could not be reached for details. Advanced Accelerator Applications S.A. , Saint Genis Pouilly, France Vect-Horus...
BioCentury | Jul 23, 2001
Company News

BioTime, Akzo Nobel NV deal

...AKZOY's Horus B.V. subsidiary will not finalize a previously announced marketing agreement with BTX for BTX's...
BioCentury | Oct 30, 2000
Tools & Techniques

Finding order amid the cacophony of data

...specific antigen) test. Clinics submit data to the Horus Global HealthNet (Hilton Head, S.C.) website. Horus...
BioCentury | Aug 3, 1998
Tools & Techniques

Derma delivery

...targets. Neural networks already are being used in diagnostics. The ProstAsure cancer detection test from Horus...
BioCentury | Jul 27, 1998
Clinical News

Horus Global HealthNet regulatory update

...of software technology to process disease markers such as serum proteins for early disease detection. Horus...
BioCentury | Oct 20, 1997
Company News

Horus Global HealthNet, Specialty Laboratories Inc. sales and marketing update

...for prostate cancer. Specialty will pay Horus a service fee on a per patient basis. Horus...
Items per page:
1 - 10 of 14
BioCentury | Jun 9, 2020
Finance

June 8 Financial Quick Takes: Novo’s REPAIR fund issues call for AMR proposals; B rounds for MabPlex, Clover; A rounds for Shorla, Curesponse

...Group, OrbiMed, China Merchants Securities, Xinzhen Tianying Fund, GF Venture Capital, Huachen Finance, Finnova Capital, Horus...
BioCentury | Mar 30, 2017
Financial News

Vect-Horus completes venture financing

...Drug delivery company Vect-Horus (Marseille, France) raised €2.5 million ($2.7 million) in a venture round from...
...round from private shareholders, including Banque Populaire Méditerranée on March 22. Vect-Horus , Marseille, France Alex Himes Vect-Horus...
BioCentury | Jul 27, 2015
Company News

Vect-Horus, Servier deal

...The companies partnered to generate new chemical entities by applying Vect-Horus’ vector technology to CNS drug...
...imaging agents using endogenous transport mechanisms across the blood-brain barrier to treat undisclosed CNS diseases. Vect-Horus...
...depending on the success of the collaboration, the companies will discuss a license under which Vect-Horus...
BioCentury | Dec 22, 2014
Financial News

Vect-Horus completes venture financing

...Vect-Horus , Marseille, France Business: Drug delivery, Neurology Date completed: 2014-12-15 Type: Venture financing Raised: €1.5...
BioCentury | Dec 9, 2013
Company News

Advanced Accelerator Applications, Vect-Horus deal

...The companies partnered to develop molecules to treat neurological diseases. Vect-Horus will use its vector technology...
...could not be reached for details. Advanced Accelerator Applications S.A. , Saint Genis Pouilly, France Vect-Horus...
BioCentury | Jul 23, 2001
Company News

BioTime, Akzo Nobel NV deal

...AKZOY's Horus B.V. subsidiary will not finalize a previously announced marketing agreement with BTX for BTX's...
BioCentury | Oct 30, 2000
Tools & Techniques

Finding order amid the cacophony of data

...specific antigen) test. Clinics submit data to the Horus Global HealthNet (Hilton Head, S.C.) website. Horus...
BioCentury | Aug 3, 1998
Tools & Techniques

Derma delivery

...targets. Neural networks already are being used in diagnostics. The ProstAsure cancer detection test from Horus...
BioCentury | Jul 27, 1998
Clinical News

Horus Global HealthNet regulatory update

...of software technology to process disease markers such as serum proteins for early disease detection. Horus...
BioCentury | Oct 20, 1997
Company News

Horus Global HealthNet, Specialty Laboratories Inc. sales and marketing update

...for prostate cancer. Specialty will pay Horus a service fee on a per patient basis. Horus...
Items per page:
1 - 10 of 14